Cargando…

Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]

Detalles Bibliográficos
Autores principales: Arkew, Mesay, Asmerom, Haftu, Tesfa, Tewodros, Tsegaye, Setegn, Gemechu, Kabtamu, Bete, Tilahun, Haile, Kassahun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974721/
https://www.ncbi.nlm.nih.gov/pubmed/36874556
http://dx.doi.org/10.2147/DMSO.S409344
_version_ 1784898772231258112
author Arkew, Mesay
Asmerom, Haftu
Tesfa, Tewodros
Tsegaye, Setegn
Gemechu, Kabtamu
Bete, Tilahun
Haile, Kassahun
author_facet Arkew, Mesay
Asmerom, Haftu
Tesfa, Tewodros
Tsegaye, Setegn
Gemechu, Kabtamu
Bete, Tilahun
Haile, Kassahun
author_sort Arkew, Mesay
collection PubMed
description
format Online
Article
Text
id pubmed-9974721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99747212023-03-02 Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter] Arkew, Mesay Asmerom, Haftu Tesfa, Tewodros Tsegaye, Setegn Gemechu, Kabtamu Bete, Tilahun Haile, Kassahun Diabetes Metab Syndr Obes Response to Letter Dove 2023-02-24 /pmc/articles/PMC9974721/ /pubmed/36874556 http://dx.doi.org/10.2147/DMSO.S409344 Text en © 2023 Arkew et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Arkew, Mesay
Asmerom, Haftu
Tesfa, Tewodros
Tsegaye, Setegn
Gemechu, Kabtamu
Bete, Tilahun
Haile, Kassahun
Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]
title Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]
title_full Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]
title_fullStr Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]
title_full_unstemmed Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]
title_short Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]
title_sort red blood cell distribution width as a biomarker in type 2 diabetes mellitus: technical notes [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974721/
https://www.ncbi.nlm.nih.gov/pubmed/36874556
http://dx.doi.org/10.2147/DMSO.S409344
work_keys_str_mv AT arkewmesay redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter
AT asmeromhaftu redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter
AT tesfatewodros redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter
AT tsegayesetegn redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter
AT gemechukabtamu redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter
AT betetilahun redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter
AT hailekassahun redbloodcelldistributionwidthasabiomarkerintype2diabetesmellitustechnicalnotesresponsetoletter